Clinical Trial Update: A Phase III Study of NK105 in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial update for NK105 in breast cancer (metastatic/recurrent) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Metastatic
• Breast Cancer Recurrent

Drugs mentioned

• NK105

Snippet

Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Breast Cancer Nos Metastatic Recurrent | Phase 3 | Status: COMPLETED | Results posted: 2019-07-29